{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T14:25:01Z","timestamp":1785507901825,"version":"3.56.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001501","name":"University Grants Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001501","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015765","name":"Guru Nanak Dev University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015765","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","award":["SPG\/2021\/000857"],"award-info":[{"award-number":["SPG\/2021\/000857"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.bioorg.2025.108781","type":"journal-article","created":{"date-parts":[[2025,7,19]],"date-time":"2025-07-19T15:01:16Z","timestamp":1752937276000},"page":"108781","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Rationally designed small peptides targeting DPP-4: Identification of potent anti-diabetic agents"],"prefix":"10.1016","volume":"163","author":[{"given":"Sombir","family":"Jaglan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Palwinder","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheetal","family":"Vermani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varinder","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarabjit","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulkadir","family":"Abdu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2025.108781_bb0005","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.2337\/dc14-S081","volume":"37","author":"Diagnosis and classification of diabetes mellitus","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/j.bioorg.2025.108781_bb0010","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/s41574-020-00443-4","article-title":"Type 1 diabetes mellitus as a disease of the \u03b2-cell (do not blame the immune system?)","volume":"17","author":"Roep","year":"2021","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.bioorg.2025.108781_bb0015","article-title":"Standards of Care in diabetes-2024","volume":"47","author":"American diabetes association professional practice committee","year":"2024","journal-title":"Diabetes Care"},{"key":"10.1016\/j.bioorg.2025.108781_bb0020","series-title":"IDF Diabetes atlas tenth edition","author":"DF Diabetes Federation","year":"2021"},{"key":"10.1016\/j.bioorg.2025.108781_bb0025","article-title":"Endothelial dysfunction in vascular complications of diabetes: a comprehensive review of mechanisms and implications","volume":"15","author":"Yang","year":"2024","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.bioorg.2025.108781_bb0030","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.pcd.2023.08.003","article-title":"Diabetes mellitus-related musculoskeletal disorders: unveiling the cluster of diseases","volume":"17","author":"Csonka","year":"2023","journal-title":"Prim. Care Diabetes"},{"key":"10.1016\/j.bioorg.2025.108781_bb0035","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.807548","article-title":"Trends in antidiabetic drug discovery: FDA approved drugs, new drugs in clinical trials and global sales","volume":"12","author":"Dahlen","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bioorg.2025.108781_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2022.155332","article-title":"Pharmacotherapy of type 2 diabetes: An update and future directions","volume":"137","author":"DeMarsilis","year":"2022","journal-title":"Metabolism"},{"issue":"1","key":"10.1016\/j.bioorg.2025.108781_bb0045","article-title":"Sodium-glucose cotransporter 2 (SGLT2) inhibitors: benefits versus risk","volume":"15","author":"Jasleen","year":"2023","journal-title":"Cureus"},{"issue":"2","key":"10.1016\/j.bioorg.2025.108781_bb0050","doi-asserted-by":"crossref","first-page":"85","DOI":"10.4239\/wjd.v13.i2.85","article-title":"Role of dipeptidyl peptidase 4 inhibitors in the new era of antidiabetic treatment","volume":"13","author":"Florentin","year":"2022","journal-title":"WJD"},{"issue":"1","key":"10.1016\/j.bioorg.2025.108781_bb0055","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s13098-023-00983-5","article-title":"Novel targets for potential therapeutic use in diabetes mellitus","volume":"15","author":"Dhankhar","year":"2023","journal-title":"Diabetol. Metab. Syndr."},{"key":"10.1016\/j.bioorg.2025.108781_bb0060","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1210\/er.2014-1035","article-title":"Pharmacology, physiology, and mechanisms of action of dipeptidyl peptidase-4 inhibitors","volume":"35","author":"Mulvihill","year":"2014","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.bioorg.2025.108781_bb0065","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2023.1150026","article-title":"Editorial: antidiabetic molecular targets: updates on old and emerging targets and their small molecule modulators","volume":"11","author":"Islam","year":"2023","journal-title":"Front. Chem."},{"key":"10.1016\/j.bioorg.2025.108781_bb0070","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2023.1130625","article-title":"DPP-4 inhibitors for treating T2DM-hype or hope? an analysis based on the current literature","volume":"10","author":"Saini","year":"2023","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.bioorg.2025.108781_bb0075","doi-asserted-by":"crossref","first-page":"389","DOI":"10.3389\/fendo.2019.00389","article-title":"Clinical use of DPP-4 inhibitors","volume":"10","author":"Gallwitz","year":"2019","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.bioorg.2025.108781_bb0080","author":"The U.S. Food and Drug Administration"},{"key":"10.1016\/j.bioorg.2025.108781_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116834","article-title":"Discovery of the selective and nanomolar inhibitor of DPP-4 more potent than sitagliptin by structure-guided rational design","volume":"279","author":"Mobeen","year":"2024","journal-title":"Eur. J. Med."},{"key":"10.1016\/j.bioorg.2025.108781_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.117160","article-title":"Design and synthesis of novel 3, 7-dihydro-1H-purine-2, 6-diones as DPP-4 inhibitors: An in silico, in vitro and in vivo approach","volume":"283","author":"Bisht","year":"2025","journal-title":"Eur. J. Med."},{"key":"10.1016\/j.bioorg.2025.108781_bb0095","article-title":"Synthesis and clinical application of representative small-molecule dipeptidyl Peptidase-4 (DPP-4) inhibitors for the treatment of type 2 diabetes mellitus (T2DM)","volume":"272","author":"Shao","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108781_bb0100","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.3390\/molecules25102293","article-title":"Peptide therapeutics 2.0","volume":"25","author":"de la Torre","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2025.108781_bb0105","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/s41573-020-00135-8","article-title":"Trends in peptide drug discovery","volume":"20","author":"Muttenthaler","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bioorg.2025.108781_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2025.141970","article-title":"Design, synthesis, and application of modified linear peptides as potential antidiabetic agent","volume":"1335","author":"Behery","year":"2025","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2025.108781_bb0115","first-page":"9","article-title":"The development of bioactive peptides from dietary proteins as a dipeptidyl peptidase IV inhibitor for the management of type 2 diabetes","volume":"5","author":"Jao","year":"2015","journal-title":"BioMedicine. (Taiwan)"},{"key":"10.1016\/j.bioorg.2025.108781_bb0120","doi-asserted-by":"crossref","first-page":"422","DOI":"10.7164\/antibiotics.37.422","article-title":"Diprotins A and B, inhibitors of dipeptidyl aminopeptidase IV, produced by bacteria","volume":"37","author":"Umezawa","year":"1984","journal-title":"J. Antibiot. (Tokyo)"},{"key":"10.1016\/j.bioorg.2025.108781_bb0125","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/0167-4838(91)90284-7","article-title":"Are diprotin A (Ile-Pro-Ile) and diprotin B (Val-Pro-Leu) inhibitors or substrates of dipeptidyl peptidase IV?","volume":"1076","author":"Rahfeld","year":"1991","journal-title":"Biochim. Biophys. Acta, Prot. struct. mol. Enzymol."},{"key":"10.1016\/j.bioorg.2025.108781_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.117134","article-title":"Designed and synthesized novel tripeptides targeting diabetes and its related pathologies","volume":"283","author":"Khan","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108781_bb0135","doi-asserted-by":"crossref","first-page":"20022","DOI":"10.1021\/acs.jmedchem.4c01987","article-title":"Proline analogues in drug design: Current trends and future prospects","volume":"67","author":"Kubyshkin","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108781_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2022.129018","article-title":"Singh, Proline based rationally designed peptide esters against dipeptidyl peptidase-4: Highly potent anti-diabetic agents","volume":"76","author":"Vivesh","year":"2022","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2025.108781_bb0145","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1021\/jm400658e","article-title":"Dipeptidyl Peptidase IV and Its Inhibitors: Therapeutics for Type 2 diabetes and what else?","volume":"57","author":"Juillerat-Jeanneret","year":"2014","journal-title":"J. Med. Chem."},{"issue":"15","key":"10.1016\/j.bioorg.2025.108781_bb0150","doi-asserted-by":"crossref","first-page":"5860","DOI":"10.3390\/molecules28155860","article-title":"Insight into structure-activity relationship of DPP-4 inhibitors for development of antidiabetic agents","volume":"28","author":"Mathur","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2025.108781_bb0155","doi-asserted-by":"crossref","first-page":"9639","DOI":"10.1021\/acs.jmedchem.1c00293","article-title":"Structure\u2013activity relationship analysis of cocrystallized gliptin-like pyrrolidine, trifluorophenyl, and pyrimidine-2,4-Dione dipeptidyl peptidase-4 inhibitor IV Inhibitor for the Treatment of Type 2 Diabetes","volume":"64","author":"Tomovic","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108781_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiolchem.2021.107597","article-title":"Virtual screening of dipeptidyl peptidase-4 inhibitors using quantitative structure\u2013activity relationship-based artificial intelligence and molecular docking of hit compounds","volume":"95","author":"Hermansyah","year":"2021","journal-title":"Comput. Biol. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108781_bb0165","doi-asserted-by":"crossref","first-page":"3208","DOI":"10.1038\/s41467-025-58493-z","article-title":"Sulphostin-inspired N-phosphonopiperidones as selective covalent DPP8 and DPP9 inhibitors","volume":"16","author":"Sewald","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioorg.2025.108781_bb0170","doi-asserted-by":"crossref","first-page":"7466","DOI":"10.1021\/acs.jmedchem.6b00475","article-title":"Comparative analysis of binding kinetics and thermodynamics of dipeptidyl peptidase-4 inhibitors and their relationship to structure","volume":"59","author":"Schnapp","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108781_bb0175","doi-asserted-by":"crossref","DOI":"10.1002\/edm2.2","article-title":"A comparative study of the binding properties, dipeptidyl peptidase-4 (DPP-4) inhibitory activity and glucose-lowering efficacy of the DPP-4 inhibitors alogliptin, linagliptin, saxagliptin, sitagliptin and vildagliptin in mice","volume":"1","author":"Berger","year":"2018","journal-title":"Endocrinol. Diabetes. Metab."},{"key":"10.1016\/j.bioorg.2025.108781_bb0180","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1002\/ptr.7392","article-title":"Protective effect of vanillic acid against diabetes and diabetic nephropathy by attenuating oxidative stress and upregulation of NF-\u03baB, TNF-\u03b1 and COX-2 proteins in rats","volume":"36","author":"Singh","year":"2022","journal-title":"Phytother. Res."},{"issue":"12","key":"10.1016\/j.bioorg.2025.108781_bb0185","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241210164","article-title":"Novel antidiabetic agents and their effects on lipid profile: A single shot for several cardiovascular targets","volume":"24","author":"Piccirillo","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2025.108781_bb0190","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1186\/s12916-022-02539-2","article-title":"New strategies to improve clinical outcomes for diabetic kidney disease","volume":"20","author":"Forst","year":"2022","journal-title":"BMC Med."},{"key":"10.1016\/j.bioorg.2025.108781_bb0195","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/j.biopha.2018.10.007","article-title":"Evaluation of antidiabetic activity of bud and flower of Avaram Senna (Cassia auriculata L.) in high fat diet and streptozotocin induced diabetic rats","volume":"108","author":"Nambirajan","year":"2018","journal-title":"Biomed. Pharmacother."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825006613?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825006613?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T05:02:06Z","timestamp":1776920526000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206825006613"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":39,"alternative-id":["S0045206825006613"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.108781","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rationally designed small peptides targeting DPP-4: Identification of potent anti-diabetic agents","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.108781","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108781"}}